Environment in Medical Technology

ISTA Pharmaceuticals Announces Positive Results for Phase IIb Study of Ecabet Sodium

... of ecabet, which were conducted in a controlled environment chamber, demonstrated positive trends in ... to demonstrate a positive effect on signs in the environment and on symptoms in the controlled environment chamber, there is now a clear path forward to ...

Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501

... The Phase 2 study utilized the controlled adverse environment (CAE) chamber to measure dry eye patients' ability to withstand a stressful drying environment on the eye, and patient diaries to measure the ... eye disease were exposed to a controlled adverse environment on day 1 and asked to self-administer either ...

TYRX Presents Early Clinical Results from AIGISRX(TM) Antibacterial Envelope Retrospective Registry

... implantable cardioverter defibrillator (ICD) in order to create a stable environment when implanted in the body. During the Heart Rhythm Society 2009 ... implantable cardioverter defibrillator (ICD) in order to create a stable environment when implanted in the body. Following commercial release in June, 2008, ...

Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrine's PS-Targeting Antibodies

... antibodies facilitate an important cytokine shift in the tumor environment that subsequently encourages multiple types of immune system cells to ... and cytokines that have the potential to alter the suppressed immune environment commonly found in tumors, attracting additional immune cells and ...

CDC Analysis Finds Unique Social and Behavior Intervention Helps Reduce MRSA Rates Up to 62% in Study Hospitals

... In other words, PD seeks to engage every person in the health care environment to identify what makes it possible for everyone who comes in contact with ... of individuals, families, communities, organizations and our natural environment by helping people use concepts emerging from the new science of complexity ...

ACRO Comments on NEJM Article on Globalization of Clinical Research

... The article cites "the increasingly bureaucratic and expensive regulatory environment in many wealthy countries" as another force that is moving clinical trials ... and other participants in the drug development process to improve the environment for clinical research while maintaining an emphasis on participant safety. ...

Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells

... cells. A large part of the problem has been inducing the proper culture environment in the laboratory. Researchers know that islets require a high amount of ... the "oxygen sandwich" to provide the cells with a more natural oxygen environment than those used in traditional culture methods. "Using mouse pancreatic ...

Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases

... see www.arvo.org . The Vision Center at Children's Hospital Los Angeles is an international referral center known for its family friendly environment of children afflicted with all forms of eye disease and provides a full range of inpatient and outpatient services. It is the largest pediatric ...

Montefiore Medical Center and Albert Einstein College of Medicine Herald New Agreement To Continue Forty-Plus Year Historic Relationship

... to spearhead new clinical trials in areas such as heart disease, cancer, pediatrics, transplant, and neurosciences; to create a model teaching environment for the 21st century; and to advance the health of the communities we serve." The new long-term agreement demonstrates a renewed level of ...

Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials

... to boost the body's ability to combat cancer via this second immunostimulatory mechanism. Further information on the role of exposed PS in the tumor environment can be found in the Anti-PS Technical Backgrounder posted at www.peregrineinc.com . About Peregrine Pharmaceuticals Peregrine ...

FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab)

... uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of ...

First Jatropha Genome Completed by Synthetic Genomics Inc. and Asiatic Centre for Genome Technology

... SGI, a privately held company founded in 2005, is dedicated to developing and commercializing genomic-driven solutions to address global energy and environment challenges. Advances in synthetic genomics present limitless applications in a variety of product areas including: energy, chemicals and ...

Type 2 Diabetes: An Epidemic Among America's Youth

... 6,400 children through middle school, from sixth to eighth grade, to determine if modifications in exercise programs and nutrition in the school environment can reduce the risk of children having the disease. Researchers are tracking the youth's body mass indices (BMIs), fasting glucose levels and ...

Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial

... airway-clearing process. It also increases the potential for bacteria to become trapped and for inflammation, thus creating an unhealthy lung environment that leads to life- threatening lung infections. Forward-Looking Statements The statements contained in this media release that are ...

Pivotal Clinical Data Published for the Only Laser Phototherapy Device Cleared by the FDA for Hair Growth

... building blocks and energy to transform from a weakened follicle to one that is healthy and capable of producing thick terminal hair. The enhanced environment in turn invigorates the hair follicle which produces healthier hair, prevents further hair loss and stimulates the re-growth of thicker terminal ....

Novagali Pharma Completed a New Phase II With Cyclokat(R) in Dry Eye

... study of 132 patients evaluated the safety and efficacy of Cyclokat(R) applied once-a-day over three months. Ora's proprietary Controlled Adverse environment (CAE) clinical model was used in this study conducted in the US. Efficacy was observed post-CAE as well as pre-CAE (environmental comparisons ...

Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase

... interoperability across local, regional, and national health information exchanges. It features advanced technology and standards in an interactive environment using test scenarios that simulate how health information is seamlessly passed across the full continuum of care. Throughout the conference CAQH ...

Worldwide Cost Estimate for Alzheimer's and Dementia Is US$315.4 Billion

... may only change the risk slightly for individuals." "More research is definitely needed," Brodaty continued, "on topics such as how genetic and environment factors interact. For now, the best evidence we have for Alzheimer's prevention points to regular physical exercise, ongoing mental activity and ...

First Year Results of the AXA Research Fund: Over Euro 13 Million Allocated for Research in 2008

... endowed with Euro 100 million over five years, making it a major initiative in the realm of scientific philanthropy in Europe. " The current environment only reinforces our conviction that academic research is critical to meeting the challenges of a global society, " noted Henri de Castries, Chairman ...

Astrocytes Help Separate Man From Mouse

... available drug aimed at brain cells. If astrocytes were important, scientists thought, it was most likely because they help create a healthy environment for the neurons. It turns out that astrocytes, which are 10 times as plentiful as neurons, had been pushed to the boundaries of neuroscience ...

ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance

... and bad faith in developing bioequivalence methods for Vancocin. OGD has gone to great lengths to avoid any consideration of the actual environment in which Vancocin will be used - patients with infected GI tracts - to the point of ignoring the cautionary statements contained in the very ...

Impact Medical Solutions Announces Initiation of Pilot Clinical Trial and Listing on Frankfurt Stock Exchange

... and estimates regarding future market conditions, company performance and financial results, business prospects, new strategies, the competitive environment and other events. You can identify these statements by the fact that they use words such as "anticipate," "believe," "estimate," "expect," "intend," ...

Aching Back? Cholesterol Medication Might Help

... been removing disc tissue from patients who are having spine surgery and extracting cells from that tissue for cultivation in vitro (a controlled environment outside of a living organism). They then transfer the cells back into the patient. Shu-Hua Yang, MD, PhD, is part of a Taiwanese research team that ...

Impact Medical Solutions Announces Appointment of New Director and Corporate Update

... and estimates regarding future market conditions, company performance and financial results, business prospects, new strategies, the competitive environment and other events. You can identify these statements by the fact that they use words such as "anticipate," "believe," "estimate," "expect," "intend," ...

Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding

... Christian Homsy, CEO of Cardio3 BioSciences commenting on today's announcement said, "Our ability to raise this level of funding in such a difficult environment reflects the significant commercial potential of C-Cure for the treatment of heart failure. The backing of our investors also demonstrates their ...

Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment

... In addition to ToleroMune's potential therapeutic benefits, its state-of-the-art manufacturing processes fit with changes in the regulatory environment in Europe where authorities are increasingly treating allergen immunotherapies in the same manner as pharmaceuticals, and eliminating the ...

Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL)

... uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of ...

Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team

... to a consultant to the Company. "While our balance sheet remains strong, the Company recognizes the challenges of the current economic environment and the need to focus our resources on our late-stage obesity programs," said Eckard Weber, M.D., the Company's Interim President and Chief Executive ...

University of Kansas Medical Center to Deploy Velos eResearch System-Wide

... Medical Center The University of Kansas Medical Center prepares students for leadership roles in today's dynamic health care environment in Schools of Medicine, Nursing and Allied Health. KU Medical Center offers more than 2,900 students an innovative curriculum and patient-centered ...

Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio

... uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of ...

The Children's Hospital of Philadelphia Announces New Regional Participant in The National Children's Study

... County Health Department. "By following 100,000 children from before birth to age 21, we hope to better understand how children's genes and their environment interact to affect their health and development," Dr. Culhane added. In November 2005, the National Children's Study named Montgomery County, Pa. ...

QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy

... often cause pain and bleeding during sexual intercourse. The decline in estrogen also contributes to an increase in vaginal pH, creating an environment more susceptible to infection. It is estimated that up to 45-75% of post-menopausal women have chronic symptoms of VVA. Current prescription ...

MedNet Solutions to Sponsor and Exhibit at the 2008 Advanced Medical Technology Association Conference in Washington, D.C.

... resulting in significant time and cost savings for sponsors, CROs and clinical sites. AdvaMed advocates for a legal, regulatory and economic environment that advances global health care by assuring worldwide patient access to the benefits of medical technology. AdvaMed's member companies produce ...

Eularis Releases First-Ever Study on ROI of Pre-Launch Named Patient Programmes

... maximize market share and optimize profits, until now, no studies have been conducted reporting on the efficacy of these programmes. In a market environment where an effective launch can result in success or failure of a pharmaceutical, evidence-based strategy is essential to launching and maintaining a ...

Quigley Anti-Viral Compound QR448(a) Successfully Prevents Transmission of Infectious Bronchitis in Chickens

... viral isolate, these results have also demonstrated that the QR448(a) compound can effectively be applied to a larger population of birds and in an environment that closely resembles a commercial scale." Dr. Mark Jackwood Professor, Department of Population Health, College of Veterinary Medicine, ...

Say 'Goodbye' to Back Fat Rolls

... widely practiced, patients need to choose an ASPS Member Surgeon who has a comprehensive understanding of how bodies change over time, the impact of environment and lifestyle and the know-how to develop the best treatment plan for the best result." According to the ASPS, more than 19,500 lower back lifts ...

NIH Funds New Wellstone Research Center for Muscular Dystrophy at Boston Biomedical Research Institute

... A key component of the Wellstone Center will be to educate and train the next generation of research and clinical scientists in an outstanding environment for muscle disease research. Like the five other Wellstone centers established since 2002, the Boston center is the legacy of Senator Paul ...

Genmab Announces Upcoming Ofatumumab Studies

... uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of ...

Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study

... uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack ...

Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study

... signal for endogenous stem cells involved in myocardial repair. -- SDF-1 modified myoblasts (SDF-MB) could undergo differentiation in the cardiac environment and assist myocardial performance, and provide a continuous source of SDF-1. Study objectives included assessment of cardiac function ...